Southwest Airlines Co. (NYSE:LUV) is getting into the football spirit by adding more nonstop flights and connections between Seattle and Phoenix Sky Harbor International Airport and Boston and Manchester and Phoenix Sky Harbor International Airport for one of the biggest sports-filled weekends of the year. The additional flights will only be offered between January 29 and February 2 to handle the anticipated increase in travelers. Southwest Airlines Co. (NYSE:LUV) belongs to Services sector. Its net profit margin is 6.30% and weekly performance is 1.34%. On last trading day company shares ended up $40.79. Southwest Airlines Co. (NYSE:LUV) distance from 50-day simple moving average (SMA50) is 1.25%.
Skyworks Solutions (NASDAQ:SWKS) CEO David J. Aldrich sold 45,000 shares of the stock on the open market in a transaction dated Wednesday, January 14th. The stock was sold at an average price of $72.00, for a total value of $3,240,000.00. Skyworks Solutions Inc. (NASDAQ:SWKS) shares increased 2.32% in last trading session and ended the day at $75.56. SWKS Gross Margin is 44.60% and its return on assets is 17.20%. Skyworks Solutions Inc. (NASDAQ:SWKS) quarterly performance is 48.30%.
Advent Software, Inc. (NASDAQ:ADVS), announced that it will release its financial results for the fourth quarter ended December 31, 2014 on Monday, February 2, 2015 after the market closes. On 20 January, Advent Software, Inc. (NASDAQ:ADVS) shares increased 2.17% and was closed at $37.75. ADVS EPS growth in last 5 year was 11.70%. Advent Software, Inc. (NASDAQ:ADVS) year to date (YTD) performance is 23.20%.
Braskem S.A. (NYSE:BAK) recently concluded a nearly $19 million-investment in Brazil that should allow it to meet the entire country’s demand for linear low density polyethylene.The company also installed new equipment at a major plant that will reap energy savings of $18.5 million annually. Braskem S.A. (NYSE:BAK) ended the last trading day at $10.16. Company weekly volatility is calculated as 3.77% and price to cash ratio as 2.33. Braskem S.A. (NYSE:BAK) showed a weekly performance of -14.33%.
On Jan 12, Cytori Therapeutics Inc. (NASDAQ:CYTX) announced that the Center for Biologics Evaluation and Research (CBER), a division of the U.S. FDA, has given final approval to its application for an Investigational Device Exemption to begin a pivotal trial, STAR trial, to evaluate Cytori Cell Therapy as a potential treatment for impaired hand function in scleroderma. Cytori Therapeutics, Inc. (NASDAQ:CYTX) shares decreased -1.99% in last trading session and ended the day at $0.47. CYTX Gross Margin is 64.40% and its return on assets is -136.80%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) quarterly performance is -8.41%.